Aimmune’s Peanut Allergy Immunotherapy Brings Safety Concerns To US FDA Panel

 
• By Sue Sutter
  
Peanut_Butter
Palforzia could be the first oral immunotherapy approved to reduce the incidence and severity of allergic reactions to peanuts. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers